Explore the Potential with AI-Driven Innovation
This extensive focused library is tailor-made using the latest virtual screening and parameter assessment technology, operated by the Receptor.AI drug discovery platform. This technique is more effective than traditional methods, offering compounds with improved activity, selectivity, and safety.
We pick out particular compounds from an extensive virtual database of more than 60 billion molecules. The preparation and shipment of these compounds are facilitated by our associate Reaxense.
The library includes a list of the most promising modulators annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Also, each compound is presented with its optimal docking poses, affinity scores, and activity scores, providing a comprehensive overview.
We utilise our cutting-edge, exclusive workflow to develop focused libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
The method includes detailed molecular simulations of the catalytic and allosteric binding pockets, along with ensemble virtual screening that considers their conformational flexibility. In the design of modulators, structural changes induced by reaction intermediates are taken into account to enhance activity and selectivity.
Several key aspects differentiate our library:
partner
Reaxense
upacc
A5YM72
UPID:
CRNS1_HUMAN
Alternative names:
ATP-grasp domain-containing protein 1
Alternative UPACC:
A5YM72; A8K1M3; B4DFC6; E9PK38; F5H427; Q8N467; Q9P2F3
Background:
Carnosine synthase 1, also known as ATP-grasp domain-containing protein 1, plays a crucial role in cellular function by catalyzing the synthesis of carnosine and homocarnosine, with a preference for carnosine. This enzymatic activity is vital for maintaining cellular homeostasis and function.
Therapeutic significance:
Understanding the role of Carnosine synthase 1 could open doors to potential therapeutic strategies. Its pivotal role in synthesizing carnosine, a dipeptide with significant biological importance, suggests its potential in modulating physiological processes and disease mechanisms.